Coroner Calls for Review of Unapproved Peptides After Australian Stuntman's Death
Published
An Australian coroner has called on the Therapeutic Goods Administration (TGA), the national regulator for medicines and medical devices, to review the use of unapproved peptides. The call follows the death of an Australian stuntman who had injected the substances.
Peptides are short chains of amino acids, the building blocks of proteins. Some are used in approved medical treatments, but many are sold online without government approval. Some people use these unapproved products to improve their physical performance or appearance, and they are often promoted on social media and websites. Because they are not checked for safety or quality, experts warn that they may contain unknown ingredients or be stored and labelled incorrectly.
The coroner's findings suggest that stronger rules could be introduced to control how these substances are sold and used in Australia. If the TGA carries out a review, it could lead to tougher restrictions on the supply of unapproved peptides. Such changes could affect online sellers, as well as people who buy and use these products.
The case has drawn attention to the risks of using substances that have not been approved for human use. Health authorities encourage anyone who is considering using peptides to speak with a doctor or pharmacist first. The TGA's response to the coroner's recommendation has not yet been announced.
Sources: The Guardian
More Australia news
- Trellis Data unveils Agentaus 1 AI model in Australia
- Australia set to run out of Q fever vaccine this week
- Missing 17-year-old William found alive in Victoria bushland
- Australia to Create New AI Safety Regulator After OpenAI Incident
- Australia Moves to Tighten AI Safety Laws After Review of OpenAI Incident
- Qantas to Cut Nearly 1,000 Jobs as It Points to Artificial Intelligence
- Australia to Introduce Mandatory AI Reporting After OpenAI Hack
- Australia Plans New AI Safety Standards and a Watchdog to Enforce Them